Atlas Trials

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

Clinical trial NCT05349266 · UNKNOWN

Trial details

NCT number
NCT05349266
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Hodgkin's Lymphoma
Start date
2022-03-18
Primary completion
2024-03-30
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.